170 related articles for article (PubMed ID: 24671053)
1. Telmisartan treatment ameliorates memory deficits in streptozotocin-induced diabetic mice via attenuating cerebral amyloidosis.
Du GT; Hu M; Mei ZL; Wang C; Liu GJ; Hu M; Long Y; Miao MX; Chang Li J; Hong H
J Pharmacol Sci; 2014; 124(4):418-26. PubMed ID: 24671053
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation.
Liu LP; Yan TH; Jiang LY; Hu W; Hu M; Wang C; Zhang Q; Long Y; Wang JQ; Li YQ; Hu M; Hong H
Acta Pharmacol Sin; 2013 Apr; 34(4):455-63. PubMed ID: 23524568
[TBL] [Abstract][Full Text] [Related]
3. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
Tsukuda K; Mogi M; Iwanami J; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
Hypertension; 2009 Oct; 54(4):782-7. PubMed ID: 19635982
[TBL] [Abstract][Full Text] [Related]
4. PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.
Jiang LY; Tang SS; Wang XY; Liu LP; Long Y; Hu M; Liao MX; Ding QL; Hu W; Li JC; Hong H
CNS Neurosci Ther; 2012 Aug; 18(8):659-66. PubMed ID: 22620268
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin ameliorates memory impairment and neurotoxicity in streptozotocin-induced diabetic mice.
Fang SC; Xie H; Chen F; Hu M; Long Y; Sun HB; Kong LY; Hong H; Tang SS
Neuroscience; 2017 Jul; 355():200-211. PubMed ID: 28499972
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors.
Shindo T; Takasaki K; Uchida K; Onimura R; Kubota K; Uchida N; Irie K; Katsurabayashi S; Mishima K; Nishimura R; Fujiwara M; Iwasaki K
Biol Pharm Bull; 2012; 35(12):2141-7. PubMed ID: 23207766
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M
Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480
[TBL] [Abstract][Full Text] [Related]
8. Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats.
Goyal BR; Mesariya P; Goyal RK; Mehta AA
Mol Cell Biochem; 2008 Jul; 314(1-2):123-31. PubMed ID: 18425420
[TBL] [Abstract][Full Text] [Related]
9. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion.
Washida K; Ihara M; Nishio K; Fujita Y; Maki T; Yamada M; Takahashi J; Wu X; Kihara T; Ito H; Tomimoto H; Takahashi R
Stroke; 2010 Aug; 41(8):1798-806. PubMed ID: 20595663
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan ameliorates germ cell toxicity in the STZ-induced diabetic rat: studies on possible molecular mechanisms.
Kushwaha S; Jena GB
Mutat Res; 2013 Jul; 755(1):11-23. PubMed ID: 23648321
[TBL] [Abstract][Full Text] [Related]
11. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.
Rajasekar N; Nath C; Hanif K; Shukla R
Mol Neurobiol; 2017 Oct; 54(8):6507-6522. PubMed ID: 27730514
[TBL] [Abstract][Full Text] [Related]
12. Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats.
Goyal BR; Parmar K; Goyal RK; Mehta AA
Pharmacol Rep; 2011; 63(4):956-66. PubMed ID: 22001983
[TBL] [Abstract][Full Text] [Related]
13. Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.
Torika N; Asraf K; Cohen H; Fleisher-Berkovich S
Brain Behav Immun; 2017 Aug; 64():80-90. PubMed ID: 28385651
[TBL] [Abstract][Full Text] [Related]
14. Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
Singh B; Sharma B; Jaggi AS; Singh N
J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):124-36. PubMed ID: 23060470
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Chang WT; Cheng JT; Chen ZC
Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
Song KH; Park JH; Jo I; Park JY; Seo J; Kim SA; Cho DH
Vascul Pharmacol; 2016 Mar; 78():43-52. PubMed ID: 26455386
[TBL] [Abstract][Full Text] [Related]
18. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
19. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
Alter ML; Ott IM; von Websky K; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Klein T; Hocher B
Kidney Blood Press Res; 2012; 36(1):119-30. PubMed ID: 23171828
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.
Kadakol A; Malek V; Goru SK; Pandey A; Gaikwad AB
Indian J Pharmacol; 2017; 49(5):348-356. PubMed ID: 29515275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
